Categories: India

‘Bharat Biotech’s Covaxin Reveals 77.8% Efficiency in phase 3 trials’

NEW DELHI: Bharat Biotech’s Covaxin has shown 77.8% effectiveness in phase 3 trials, also reported ANI pruning resources.
The Hyderabad-based company had previously submitted the trial information to the Subject Expert Committee (SEC) of the Indian medication regulator.
The panel has accepted the trial information.
The trials have been conducted 25,800 subjects, according to reports.
Bharat Biotech’s indigenously developed Covaxin is among the 3 vaccines currently being used in India.
Covishield, produced by AstraZeneca and fabricated locally by Serum Institute of India and also Russia’s Sputnik V would be another two vaccines administered The firm has established the vaccine from conjunction with the Indian Council of Medical Research (ICMR).

news2in

Share
Published by
news2in

Recent Posts

44 ordered to attack the procession

Ludhiana: The police have submitted FIR to four identified and at least 40 unknown attackers…

3 years ago

Punjab: Police Reject conspiracy theory in the case of Deep Sidhu

Sonīpat / Ludhiana / Ambala: Actor Punjabi - Activist Activist Deep Sidhu, who died in…

3 years ago

Punjab: Hidden Strength Working Behind PM Narendra Modi, Arvind Kejriwal, said Rahul Gandhi

PATIALA / MANSA / BARNALA: Attacking Prime Minister Narendra Modi and AAP National Convener Kejriawal,…

3 years ago

BJP made AAP to endanger the Congress, said Ajay

Jalandhar: BJP and AAM AAM AADMI parties are one party, Secretary General of the Ajay…

3 years ago

Our job is to make Punjab No. 1 State: Meenakshi Lekhi

Ludhiana: Minister of Union Culture Meenakshi Lekhi while campaigning to support the BJP candidate from…

3 years ago

Feb 20 is an opportunity to change the destiny of Punjab and his children: Bhagwant Mann

Machhiwara (Ludhiana): AAM AAM AADMI Party (AAP) Head of Punjab Candidate and Members of Parliament…

3 years ago